IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v604y2022i7905d10.1038_s41586-022-04652-x.html
   My bibliography  Save this article

Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

Author

Listed:
  • Edward Seung

    (Sanofi R&D, North America
    ModeX Therapeutics)

  • Zhen Xing

    (Sanofi R&D, North America)

  • Lan Wu

    (Sanofi R&D, North America
    ModeX Therapeutics)

  • Ercole Rao

    (Sanofi R&D, Frankfurt)

  • Virna Cortez-Retamozo

    (Sanofi R&D, North America)

  • Beatriz Ospina

    (Sanofi R&D, North America)

  • Liqing Chen

    (Sanofi R&D, North America)

  • Christian Beil

    (Sanofi R&D, Frankfurt)

  • Zhili Song

    (Sanofi R&D, North America)

  • Bailin Zhang

    (Sanofi R&D, North America)

  • Mikhail Levit

    (Sanofi R&D, North America)

  • Gejing Deng

    (Sanofi R&D, North America)

  • Andrew Hebert

    (Sanofi R&D, North America)

  • Patrick Kirby

    (Sanofi R&D, North America
    Dragonfly Therapeutics)

  • Aiqun Li

    (Sanofi R&D, North America)

  • Emma-Jane Poulton

    (Sanofi R&D, North America)

  • Rita Vicente

    (Sanofi R&D, Montpellier)

  • Audrey Garrigou

    (Sanofi R&D, Montpellier)

  • Peter Piepenhagen

    (Sanofi R&D, North America)

  • Greg Ulinski

    (Sanofi R&D, North America)

  • Michele Sanicola-Nadel

    (Sanofi R&D, North America
    GSK)

  • Dinesh S. Bangari

    (Sanofi R&D, North America)

  • Huawei Qiu

    (Sanofi R&D, North America)

  • Lily Pao

    (Sanofi R&D, North America)

  • Dmitri Wiederschain

    (Sanofi R&D, North America
    Jounce Therapeutics)

  • Ronnie Wei

    (Sanofi R&D, North America
    ModeX Therapeutics)

  • Zhi-yong Yang

    (Sanofi R&D, North America
    ModeX Therapeutics)

  • Gary J. Nabel

    (Sanofi R&D, North America
    ModeX Therapeutics)

Abstract

No abstract is available for this item.

Suggested Citation

  • Edward Seung & Zhen Xing & Lan Wu & Ercole Rao & Virna Cortez-Retamozo & Beatriz Ospina & Liqing Chen & Christian Beil & Zhili Song & Bailin Zhang & Mikhail Levit & Gejing Deng & Andrew Hebert & Patri, 2022. "Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells," Nature, Nature, vol. 604(7905), pages 13-13, April.
  • Handle: RePEc:nat:nature:v:604:y:2022:i:7905:d:10.1038_s41586-022-04652-x
    DOI: 10.1038/s41586-022-04652-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-022-04652-x
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-022-04652-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:604:y:2022:i:7905:d:10.1038_s41586-022-04652-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.